| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1165/RCMB.F249 |
| P698 | PubMed publication ID | 12356570 |
| P50 | author | Adam V Wisnewski | Q91364881 |
| P2093 | author name string | Terry Gordon | |
| Carrie A Redlich | |||
| P2860 | cites work | Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers | Q23910898 |
| Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma | Q23911725 | ||
| Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate | Q23912396 | ||
| Importance of inflammatory and immune components in a mouse model of airway reactivity to toluene diisocyanate (TDI). | Q23913978 | ||
| Selecting isocyanate sampling and analytical methods | Q23920362 | ||
| Role of tumor necrosis factor in toluene diisocyanate asthma | Q26160376 | ||
| Characterization of murine immune responses to allergenic diisocyanates | Q28319055 | ||
| Cytokine secretion patterns of T cells responding to haptenized-human serum albumin in toluene diisocyanate (TDI)-induced asthma patients | Q28369232 | ||
| Current diagnostic methods for diisocyanate induced occupational asthma | Q33724281 | ||
| Mechanisms of occupational asthma | Q33808131 | ||
| Outcome determinants for isocyanate induced occupational asthma among compensation claimants | Q33821036 | ||
| Diisocyanate asthma: clinical aspects and immunopathogenesis | Q34506444 | ||
| Upper airway disorders and asthma: a syndrome of airway inflammation | Q34625509 | ||
| Rhinitis, sinusitis and asthma: one linked airway disease | Q34674341 | ||
| Modeling allergic asthma in mice: pitfalls and opportunities | Q34805236 | ||
| The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways | Q35884572 | ||
| Diisocyanate-exposed auto body shop workers: a one-year follow-up | Q38486699 | ||
| Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate | Q38574818 | ||
| Immunotoxicologic evaluation of the respiratory system: animal models for immediate- and delayed-onset pulmonary hypersensitivity | Q39494843 | ||
| Overview of diisocyanate occupational asthma | Q41035593 | ||
| The role of the skin in the development of chemical respiratory hypersensitivity | Q41035765 | ||
| Respiratory hypersensitivity in guinea pigs sensitized to 1,6-hexamethylene diisocyanate (HDI): comparison of results obtained with the monomer and homopolymers of HDI. | Q42165254 | ||
| Isolated airway exposure to toluene diisocyanate results in skin sensitization | Q43581546 | ||
| Inhalation toxicity of 1,6-hexamethylene diisocyanate homopolymers (HDI-IC and HDI-BT): results of subacute and subchronic repeated inhalation exposure studies | Q43668685 | ||
| Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure | Q43686372 | ||
| A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor | Q43821994 | ||
| Pulmonary function tests at work | Q43852072 | ||
| Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma | Q43926005 | ||
| A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge | Q43982686 | ||
| Toluene diisocyanate protein adducts in the bronchoalveolar lavage of guinea pigs exposed to vapors of the chemical | Q46532252 | ||
| Occupational asthma, IgE and IgG. | Q47793642 | ||
| Immunization and challenge with toluene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways | Q47876024 | ||
| Con: mice are not a good model of human airway disease. | Q51712241 | ||
| Pro: mice are a good model of human airway disease. | Q51712244 | ||
| Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. | Q54100405 | ||
| Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure | Q58192653 | ||
| Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma | Q58877324 | ||
| P433 | issue | 4 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 385-390 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Mouse models of diisocyanate asthma | |
| P478 | volume | 27 |
| Q38453111 | A case of isocyanate-induced asthma possibly complicated by food allergy after peanut consumption: a case report. |
| Q48626443 | Airway inflammation and bronchial remodelling in toluene diisocyanate-exposed BALB/c mouse model |
| Q38503730 | Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model |
| Q46928276 | Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): impact of vehicle for topical induction |
| Q35962513 | Maternal allergic contact dermatitis causes increased asthma risk in offspring |
| Q34323493 | Persistence of asthmatic response after ammonium persulfate-induced occupational asthma in mice |
| Q23912076 | Polyisocyanates in occupational environments: a critical review of exposure limits and metrics |
Search more.